Germany's Merck seeks partners for cancer and immune system drugs

FRANKFURT (Reuters) – Merck KGaA will seek development partners for experimental treatments including tepotinib as the German company looks to licensing deals to help fund clinical trials, according to its head of drug R&D.


Source: Reuters Health

Leave a Reply

Your email address will not be published. Required fields are marked *